We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

158 hedge funds and large institutions have $898M invested in Collegium Pharmaceutical in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 61 increasing their positions, 43 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 43

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% less capital invested

Capital invested by funds: $900M → $898M (-$2.6M)

1.58% less ownership

Funds ownership: 109.35% → 107.77% (-1.6%)

3% less funds holding

Funds holding: 163 → 158 (-5)

15% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 20

88% less call options, than puts

Call options by funds: $2K | Put options by funds: $16K

Holders
158
Holders Change
-5
Holders Change %
-3.07%
% of All Funds
2.75%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
61
Reduced
43
Closed
20
Calls
$2K
Puts
$16K
Net Calls
-$14K
Net Calls Change
-$1M

Top Buyers

1
Principal Financial Group
Principal Financial Group
Iowa
+$7.48M
2
EAM
Eventide Asset Management
Massachusetts
+$4.66M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$4.47M
4
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$4.37M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$3.96M

Top Sellers

1
APM
Avidity Partners Management
Texas
-$17.5M
2
SAM
Silvercrest Asset Management
New York
-$5.3M
3
BlackRock
BlackRock
New York
-$5.08M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.16M
5
RHJA
Rice Hall James & Associates
California
-$2.92M
Name Holding Trade Value Shares
Change 		Change in
Stake
FP
26
Foundry Partners
Minnesota
$5.75M -$52.2K -2,259 -0.9%
Deutsche Bank
27
Deutsche Bank
Germany
$5.63M +$3.77M +163,014 +217%
Bank of Montreal
28
Bank of Montreal
Ontario, Canada
$4.82M +$402K +17,385 +10%
LPL Financial
29
LPL Financial
California
$4.57M -$45.3K -1,961 -1%
Goldman Sachs
30
Goldman Sachs
New York
$4.19M -$291K -12,612 -7%
Federated Hermes
31
Federated Hermes
Pennsylvania
$4.06M +$3.96M +171,379 +76,168%
Ameriprise
32
Ameriprise
Minnesota
$3.81M -$566K -24,522 -13%
PPA
33
Parametric Portfolio Associates
Washington
$3.22M +$94.7K +4,100 +3%
Millennium Management
34
Millennium Management
New York
$3.19M +$1.36M +58,847 +78%
Wells Fargo
35
Wells Fargo
California
$3M -$367K -15,900 -11%
SDIC
36
South Dakota Investment Council
South Dakota
$2.51M +$2.45M +106,182 New
Neuberger Berman Group
37
Neuberger Berman Group
New York
$2.45M +$32.3K +1,399 +1%
Victory Capital Management
38
Victory Capital Management
Texas
$2.41M +$1.02M +44,179 +77%
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$2.39M -$77.1K -3,336 -3%
HVC
40
Healthcare Value Capital
New Jersey
$2.36M – – –
JGC
41
J. Goldman & Co
New York
$2.28M +$457K +19,790 +26%
JIC
42
Johnson Investment Counsel
Ohio
$2.15M -$3.97K -172 -0.2%
Pacer Advisors
43
Pacer Advisors
Pennsylvania
$2.14M +$2.09M +90,402 New
BGIM
44
Brandywine Global Investment Management
Pennsylvania
$1.86M -$120K -5,205 -6%
Legal & General Group
45
Legal & General Group
United Kingdom
$1.75M -$543K -23,499 -24%
Public Sector Pension Investment Board (PSP Investments)
46
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.7M – – –
American Century Companies
47
American Century Companies
Missouri
$1.67M +$411K +17,785 +34%
MCM
48
Manchester Capital Management
Vermont
$1.64M – – –
Swiss National Bank
49
Swiss National Bank
Switzerland
$1.63M -$50.8K -2,200 -3%
MPAM
50
Monarch Partners Asset Management
Massachusetts
$1.56M +$580K +25,090 +61%
1
2
3 4 5

COLL Hedge Fund Activity: Q2 2021 in Review

158 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q2 2021, worth a combined $898M — down 0.29% from $900M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of COLL and 17 opened new positions — a net loss of 3 holders — while 43 trimmed existing stakes and 61 added.

The largest buyer was Principal Financial Group, adding an estimated $7.48M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $17.5M sold.

  • 158 institutional investors held Collegium Pharmaceutical (COLL) as of Q2 2021, down from 163 in Q1 2021.
  • Funds reported $898M of Collegium Pharmaceutical stock for Q2 2021, down 0.29% quarter-over-quarter.
  • 17 funds opened new Collegium Pharmaceutical positions in Q2 2021 and 20 closed out, a net change of -3 holders.
  • The largest Collegium Pharmaceutical buyer in Q2 2021 was Principal Financial Group, an estimated $7.48M added.
  • The largest Collegium Pharmaceutical seller in Q2 2021 was Avidity Partners Management, an estimated $17.5M sold.

Based on aggregated 13F filings for Q2 2021.